| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.33 | 0.06 |